|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.350 USD | +2.17% |
|
+8.80% | +30.56% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 11 | +368.09% | 2 | |||||
| 1,220.39 | -0.78% | 28 | ||||||
| 257.5 | -0.39% | 22 | ||||||
| 256.14 | +0.72% | 28 | ||||||
| 358.83 | +5.91% | 18 | ||||||
| 220.67 | +16.5% | 21 | ||||||
| 154.49 | -1.05% | 21 | ||||||
| 315.24 | +0.11% | 24 | ||||||
| 354.76 | -1.61% | 29 | ||||||
| 157.67 | +24.81% | 27 | ||||||
| 29.15 | +19.62% | 27 | ||||||
| 548.69 | +9.81% | 29 | ||||||
| 63 | +7.58% | 24 | ||||||
| 20.92 | +5.69% | 19 | ||||||
| 96.7 | +28.09% | 23 | ||||||
| 9,973.33 | +31.68% | 15 | ||||||
| 51.64 | +12.19% | 18 | ||||||
| 6,106.87 | +17.98% | 15 | ||||||
| 81.14 | +53.29% | 16 | ||||||
| Average | 1,067.27 | +31.49% | 21 | ||||||
| Weighted average by Cap. | 717.91 | +5.42% | 24 |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
